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Abstract
The mechanism of PKAc-dependent NF-kB activation and subsequent translocation into the nucleus is not well defined.
Previously, we showed that A kinase interacting protein 1 (AKIP1) was important for binding and retaining PKAc in the
nucleus. Since then, other groups have demonstrated that AKIP1 binds the p65 subunit of NF-kB and regulates its
transcriptional activity through the phosphorylation at Ser 276 by PKAc. However, little is known about the formation and
activation of the PKAc/AKIP1/p65 complex and the rate at which it enters the nucleus. Initially, we found that the AKIP1
isoform (AKIP 1A) simultaneously binds PKAc and p65 in resting and serum starved cells. Using peptide arrays, we refined
the region of AKIP 1A binding on PKAc and mapped the non-overlapping regions on AKIP 1A where PKAc and p65 bind. A
peptide to the amino-terminus of PKAc (CAT 1-29) was generated to specifically disrupt the interaction between AKIP 1A
and PKAc to study nuclear import of the complex. The rate of p65 nuclear translocation was monitored in the presence or
absence of overexpressed AKIP 1A and/or (CAT 1-29). Enhanced nuclear translocation of p65 was observed in the presence
of overexpressed AKIP1 and/or CAT 1-29 in cells stimulated with TNFa, and this correlated with decreased phosphorylation
of serine 276. To determine whether PKAc phosphorylation of p65 in the cytosol regulated nuclear translocation, serine 276
was mutated to alanine or aspartic acid. Accelerated nuclear accumulation of p65 was observed in the alanine mutant, while
the aspartic acid mutation displayed slowed nuclear translocation kinetics. In addition, enhanced nuclear translocation of
p65 was observed when PKAc was knocked-down by siRNA. Taken together, these results suggest that AKIP 1A acts to
scaffold PKAc to NF-kB in the cytosol by protecting the phosphorylation site and thereby regulating the rate of nuclear
translocation of p65.
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Introduction
Translocation of the ubiquitous cAMP-dependent protein
kinase (protein kinase A; PKA) to specific sites in cells helps elicit
selective responses to biological inputs from external stimuli
[1,2,3]. Targeting and compartmentalization of PKA has been
mostly thought to be mediated by A-kinase-anchoring proteins
(AKAPs) that bind the dimerization/docking domain of the
regulatory subunits and scaffold PKA to substrates [4,5,6,7,8,9].
Activation of the PKA catalytic subunit (PKAc) following cAMP
stimulation, results in from the regulatory subunits and phos-
phorylation of substrates proximal to or tethered at AKAPs.
Catalytically active PKAc also translocates to the nucleus where it
phosphoylates the transcription factor cAMP response element
binding protein (CREB) to regulate gene expression [10]. A
Kinase Interacting Protein (AKIP1) was identified as a novel
PKAc binding protein that targets PKAc to specific locations
within cells [11]. AKIP1 binds the amino terminal tail of PKAc
(N-Tail: residues 1-39). The N-Tail is a genetically diverse region
in the protein that precedes the conserved core and acts to target
the protein to distinct subcellular locations through myristylation,
phosphorylation, and deamidation [12,13,14,15,16]. One of the
functions of AKIP1 appears to be retention of PKAc in the nucleus
of cells [11].
PKAc has also been shown to be associated with the NF-kB:IkB
complex. NF-kB is a transcription factor that induces the expre-
ssion of genes involved in many biological responses including
inflammation, cell proliferation, and survival [17,18,19,20,21].
The majority of NF-kB exists as a heterodimer of p65/p50
proteins sequestered in the cytosol and bound to inhibitory IkB
proteins [22]. Stimulation of cells with cytokines, including TNFa,
activate IkB kinases that phosphorylate IkB and result in
ubiquitination and proteosomal degradation of the protein
[23,24,25]. The free p65/p50 complex enters the nucleus and
initiates transcription of downstream effector genes [26,27].
Identification of cytosolic complexes containing NF-kB, IkB, and
PKAc have previously demonstrated that cAMP independent
signaling may play a regulatory role in NF-kB mediated nuclear
translocation and transcription [28]. Phosphorylation by PKAc
was mapped to serine 276 in the p65 subunit of NF-kB, and
showed pleiotropic effects including recruitment of CREB binding
protein/p300 and subsequent acetlyation, as well as displacement
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recently been studied through mutational analysis. Mutation of
serine 276 to alanine is embryonic lethal despite translocation to
the nucleus and interaction with DNA, demonstrating the
regulatory importance of this site [32].
Two recent studies identified AKIP1 as a p65 binding protein
[33,34]. In the first study, the 1B isoform of AKIP1, upon
neddylation, was found to bind p65, and recruit histone
deacetylase, SirT1, to the complex resulting in transcriptional
repression [33]. The second study identified p65 as an AKIP 1A
binding partner through a yeast two-hybrid screen. AKIP 1A was
recruited to a nuclear complex that contained p65 and PKAc. The
net result of this complex was an increase in NF-kB dependent
transcription.
In this study, we wanted to examine the effect of PKAc and
AKIP1 on the rate of translocation of NF-kB into the nucleus. We
provide evidence that AKIP1 acts as a molecular scaffold that
simultaneously binds PKAc and p65 in the cytosol and disruption
of this complex alters the rate at which NF-kB enters the nucleus.
Our data also suggests that phosphorylation of p65 by PKAc is
abrogated by AKIP1 in the cytosol and this allows p65 to
translocate faster into the nucleus.
Results
AKIP1 binds to PKAc and enhances its transcriptional
activity upon stimulation
Previous work identified AKIP1 as a PKA binding protein that
regulates nuclear localization of the catalytic subunit of PKA
(PKAc) (11). Three AKIP1 isoforms have been identified, but no
information exists on how these different isoforms bind PKAc in
resting and stimulated cells. In initial studies, the ability of each
AKIP1 isoform to bind endogenous PKAc was evaluated (Fig. 1A).
GST-tagged AKIP 1A, AKIP 1B, and AKIP 1C bound PKAc in
resting HEK 293 cells (lanes 5–7), but not GST alone (lane 8).
Each AKIP1 isoform, as well as GST alone, expressed and bound
to beads equally (lanes 1–4). Since there was a preference for
PKAc to bind AKIP 1A stronger than other AKIP1 isoforms (lane
5), this isoform was used throughout this study. Treatment of HEK
293 cells with 8-CPT-cAMP for 1 hour to activate PKAc
disrupted the interaction of PKAc with all three AKIP1 isoforms.
To further confirm that overexpression of AKIP1 facilitates
translocation of PKAc into the nucleus, PKAc-mediated tran-
scription was explored. Previously, HeLa cells overexpressing
AKIP1 demonstrated enhanced nuclear accumulation of endog-
enous PKAc, and this effect could be blocked by disruption of the
AKIP1-PKAc interaction. To determine whether the observed
enhanced PKAc nuclear translocation resulted in a functional
change, HeLa cells were co-transfected with mCherry-AKIP 1A
and a luciferase gene reporter downstream of a cAMP response
element (Fig. 1B) and stimulated with forskolin (to increase
intracellular cAMP levels) and IBMX (a phosphodiesterase
inhibitor) for 0, 30, 60 and 120 minutes. Upon activation,
enhanced luciferase activity was observed in cells expressing
mCherry AKIP 1A, suggesting that AKIP1 acts to shuttle PKAc
into the nucleus and subsequently dissociate from it.
Formation of a multiprotein complex containing AKIP 1A,
PKAc, and p65
PKAc and the p65 subunit of NF-kB were identified from two
independent yeast two-hybrid screens as AKIP1 binding proteins.
In the presenceof phorbol esters, Gao et al. observed a complex of C
subunit, AKIP 1A and p65 and hypothesized that this complex
forms in the nucleus (34). To extend these observations, we first
wanted to determine whether this complex was present in whole cell
lysates from serum starved cells, or in cells stimulated with 8-CPT-
cAMP or TNFa (Fig. 2). In starved cells, both endogenous PKAc
and p65 were immunoprecipitated by Myc-AKIP 1A (lane 4), but
not a control Myc vector alone (lane 1). Consistent with previous
observations (Fig. 1A), stimulation of cells with 8-CPT-cAMP
resulted in a significant decrease in PKAc binding to AKIP 1A (lane
5, top panel), but the interaction of p65 with AKIP 1A was not
significantly altered (lane 5, second panel). Similar to previously
published results, stimulation with TNFa had no significant effect
on the interaction of AKIP1 with either PKAc or p65 (lane 6, top
twopanels)(34).Inotherexperiments,stimulationofcellswithPMA
did not alter interaction of AKIP 1A with PKAc or p65 (data not
shown). In the presence of vector alone, neither the PKAc nor p65
was pulled down in resting or stimulated cells (lanes 1–3).
Once it was determined that AKIP 1A, PKAc, and p65 interact
in resting or serum starved cells, we next wanted to determine
whether the interaction was formed in the cytosol or nucleus. Both
Myc-AKIP 1A and Flag-p65 interacted in the cytosol of resting
cells (Fig. 3A, lanes 2 and 4), while control immunoprecipitations
did not (Fig. 3A, lanes 1 and 3). The presence and purity of the
cytosolic fraction was by determined using the cytosolic marker
tubulin-a and the nuclear marker, Lamin B. Epifluorescence
microscopy was employed to further explore whether p65 and
AKIP 1A co-localize in the cytosol of unstimulated cells. A merged
image of mCherry AKIP and GFP-p65 indicated that the two
proteins were found at similar cytosolic and nuclear locations
when compared with a diffusely localized mCherry vector alone
(Fig. 3B). To determine whether the complex between AKIP 1A,
PKAc, and p65 formed in the cytosol, overexpressed Myc-AKIP
1A was immunoprecipitated from cytosolic fractions of HeLa cells
(Fig. 3C). In unstimulated and 8-CPT-cAMP stimulated cells both
PKAc and p65 were associated with Myc-AKIP 1A (lanes 2 and 4,
top panels). Control immunoprecipitations did not significantly
bind endogenous PKAc or p65 (lanes 1 and 3). To determine
whether the PKAc/AKIP 1A/p65 complex was a distinct complex
from the p65/p50/IkBa complex, we also tested whether IkBa
was in the complex with AKIP 1A immunoprecipitation. IkBa was
present in the complex, suggesting that the AKIP 1A bound pool
of p65 overlaps with the larger p65/p50/IkBa complex (panel 3).
The observation that PKAc is associated with Myc-AKIP 1A in
the cytosol of 8-CPT-cAMP stimulated cells indicates that the
dissociation of PKAc from AKIP1A occurs after translocation into
the nucleus (see Discussion).
Defining primary binding region of AKIP 1A on PKAc
PKAc preferentially interacts with the AKIP 1A isoform, and
the PKAc binding site was previously mapped to the amino
terminus. To further map the interaction site(s) on PKAc, we
performed a peptide walk to determine specific amino acids
required for PKAc to bind to the three AKIP1 splice variants.
Specifically, 15-mer peptides derived from the amino terminal 38
amino acids of PKAc were spotted onto a membrane and overlaid
with in vitro translated AKIP 1A, AKIP 1B, or AKIP 1C proteins
as previously described [11]. The three AKIP1 isoforms
specifically bound clusters of sequences, shown in Fig. 4A, with
the sequence of the spotted peptide shown to the right of the
peptide spot. The complete peptide walk of AKIP 1A over the
amino terminus of PKAc and the identified binding sites are
shown in Figure S1. Exposed lysines at either end of the peptide
appear to enhance AKIP1 binding to PKAc. To further define the
optimal binding regions and critical amino acids within this region,
peptides containing amino acids 11–30 were systematically
shortened by one amino acid from the amino and/or carboxy
AKIP and PKA Regulate p65 Nuclear Translocation
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composed of amino acids 15–29 was identified as a minimal
binding region. Figure 4B indicates the exposed amino acids on
the solvent exposed surface of the N-terminal helix of PKAc that
are thought to be important for interaction with AKIP 1A.
Previously, AKIP1 was found to enhance translocation of PKAc
into the nucleus of HeLa cells stimulated with forskolin [11]. To
determine whether this minimal peptide could disrupt the interaction
of PKAc and AKIP 1A, HA-tagged 1-29 PKAc peptide (CAT 1-29)
was co-transfected into HeLa cells with GST-AKIP 1A (Fig. 4C).
Cells transfected with CAT 1-29 and GST-AKIP 1A had a
significantly reduced capacity to pull down endogenous PKAc (lane
4). However, transfection with either a scrambled CAT 1-29 (SCR
CAT 1-29; lane 5) or a 1-29 peptide in which two prolines were
addedtodisrupt thealpha helicalstructure (CAT 1-29 proline; lane6)
did not interfere with PKAc binding to GST-AKIP 1A. In mock
Figure 1. The AKIP 1A isoform binds to endogenous PKAc and enhances transcription. A) Western blots of detergent soluble lysates from
HEK 293 cells alone or incubated with 8-CPT-cAMP (50 mM) showing immunoprecipitated and total protein levels for transfected GST AKIP constructs
and endogenous PKAc. Lysates containing GST- AKIP 1A, AKIP 1B, AKIP 1C, and GST alone were incubated with GST resin (GE Healthcare) for 1 h,
washed, and analyzed on 10% SDS-PAGE and western blotted with anti-GST antibody (lanes 1–4), anti-PKAc antibody (lanes 5–8), or both (lanes 9–
12). B) HeLa cells were transfected with the cAMP response element upstream of the luciferase reporter in the presence of either mCherry-AKIP 1A or
mCherry alone. Cells were treated with forskolin for up to 2 hours and PKAc dependent transcription was measured.
doi:10.1371/journal.pone.0018713.g001
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enous PKAc was similar to the scrambled peptide (data not shown).
Quantification of the interaction of endogenous PKAc with GST-
AKIP 1A in the presence of CAT 1-29, scrambled CAT 1-29, and
CAT 1-29 proline is shown in Fig. 4D, illustrating a decrease in
binding using the CAT 1-29 disruptor peptide compared to the
controls. Next, we tested whether transfection of cells with Myc-AKIP
1A and the wild-type CAT 1-29 disrupting peptide could block
nuclear import of endogenous PKAc and provide evidence for a
biological function (Fig. 4E). Nuclear PKAc from fractionated HeLa
cells, as determined by the presence of lamin B, was measured (data
not shown). In agreement with previous reports [34], PKAc
redistributed to the nucleus upon stimulation with either 8-CPT
cAMP or TNFa. Translocation was partially blocked upon addition
of CAT 1-29 either in the presence of 8-CPT cAMP or TNFa, but
not with scrambled CAT 1-29. Taken together, these results suggest
that a peptide encompassing the first 29 amino acids of PKAc
effectively disrupts the AKIP 1A-PKAc interaction and decreases
nuclear import of PKAc.
Defining primary binding region of PKAc and p65 on
AKIP 1A
Our studies demonstrate that both PKAc and p65 directly bind
AKIP 1A and immunoprecipitation experiments indicate that this
complex exists in the cytosol of serum starved cells. Therefore,
using peptide blot analysis, we next wanted to determine whether
the binding sites of PKAc and p65 on AKIP 1A were similar or
distinct (Fig. 5A and B). To identify PKAc binding sites, 15-mer
peptides encompassing the entire AKIP 1A protein were spotted
onto a membrane and incubated with recombinant purified
PKAc. PKAc bound two specific clusters of amino acids, the first
in exon 1 at the amino terminus of AKIP 1A and the second in
exons 5 and 6 (Fig. 5A). To identify p65 binding sites, 18-mer
peptides encompassing the entire AKIP 1A protein were spotted
onto a membrane and incubated with in vitro translated p65
protein (Fig. 5B). The region of p65 binding was further narrowed
to identify specific binding determinants (data not shown). The
results indentified a binding site on AKIP 1A that did not overlap
with the PKAc binding site. The amino acids required for p65
interaction with AKIP 1A encompassed a 12-mer peptide of
GGATHVYRYHRG.
Determining the rate of PKAc and AKIP1 mediated p65
translocation
Once the binding regions of AKIP 1A with PKAc and p65 had
been identified, we next wanted to determine whether disruption of
the complex played a functional role in cells. First, we tested
whether disrupting the interaction had an effect on the rate of
nuclear accumulation of p65 in response to TNFa. HeLa cells were
transfected with GFP-p65 alone (Fig. 6A), or in the presence of
either CAT 1-29 peptide (Fig. 6B), mCherry AKIP 1A (Fig. 6C), or
withboth CAT1-29 peptide andmCherryAKIP1A (Fig.6D). Cells
were stimulated for up to 45 minutes with TNFa and nuclear
accumulation of GFP-p65 over the course of the experiments was
measured by epifluorescence microscopy. Over the TNFa time
course,GFP-p65translocated to the nucleus at a rate comparable to
what others have observed [35]. Disruption of the interaction
between PKAc and AKIP 1A by expression of the CAT 1-29
acceleratednuclearaccumulation ofGFP-p65 (compareFig.6Aand
Fig. 6B, 30 min time points). A more dramatic effect on the nuclear
accumulation of GFP-p65 was observed when mCherry AKIP 1A
alone was over expressed (Fig. 6C; see Discussion). Within 15
minutes of TNFa stimulation, a majority of the GFP-p65 had
accumulated in the nucleus of HeLa cells overexpressing mCherry
AKIP 1A. Double expression of CAT 1-29 and mCherry AKIP 1A
resulted in nuclear accumulation of GFP-p65 in the absence of
stimulus (Fig. 6D). To ensure that translocation of endogenous p65
was similar to GFP-p65, biochemical fractionation of HeLa cell
lysatewasperformed on untransfectedcells (Fig. 6E, lanes 1–4),cells
transfected with mCherry AKIP 1A (lanes 5–8), scrambled CAT 1-
29 (lanes 9–12), CAT 1-29 (lanes 13–16), or cells transfected with
both mCherry AKIP 1A and CAT 1-29 (lanes 17–20). In
untransfected cells, endogenous p65 was primarily excluded from
the nucleus in starved cells in the absence of stimulus and gradually
accumulated in the nuclear fraction during the 45 minute
stimulation with TNFa. Cells transfected with either mCherry
AKIP 1A (lanes 5–8) or CAT 1-29 (lanes 13–16) both displayed
enhanced nuclear translocation of p65 in response to TNFa, but
translocation of p65 in cells transfected with scrambled CAT 1-29
did not change significantly compared with untransfected cells
(Fig. 6F). As with the GFP-p65, the double transfection of mCherry
AKIP 1A and CAT 1-29 resulted in a substantial increase in the
amount of p65 found in the nucleus in the absence of TNFa when
compared with the total amount of p65 detected from whole cell
lysates from the same samples (lanes 17–20). The relative amount of
nuclear p65 compared withtotal p65 under eachof these conditions
from multiple experiments is plotted in Fig. 6F. The same effect of
mCherry AKIP 1A and CAT 1-29 was observed when cells were
stimulated with TNFa/8-CPT-cAMP (Figure S3). We next wanted
Figure 2. Interaction of PKAc with AKIP 1A is stimulus
dependent, but the interaction of p65 remains constant. HEK
293 cells were transiently transfected with cDNA for wild-type Myc-AKIP
1A (lanes 4–6) or control vector (lanes 1–3). Cells were stimulated with
8-CPT-cAMP (50 mM; lanes 2 and 5) or TNFa (1 ng/ml; lanes 3 and 6) for
60 min and probed for endogenous PKAc, p65, and actin, as well as Myc
by Western blot.
doi:10.1371/journal.pone.0018713.g002
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PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18713Figure 3. The p65 subunit of NF-kB binds AKIP 1A in the cytosol of unstimulated HEK 293 cells. A) (left) HEK 293 cells were transfected
with Myc-AKIP 1A in the presence or absence of Flag-p65 WT. Cells were fractionated as described in the Methods section to yield a cytosolic fraction
and Myc-AKIP 1A was immunoprecipitated and separated by SDS-polyacrylamide gels followed by Western blotting for Flag-p65. (right) HEK 293 cells
were transfected with Flag-p65 WT in the presence or absence of Myc-AKIP 1A and fractionated as described above. Samples were Western blotted
for Myc-AKIP 1A. Both fractions were free from nuclear contamination based on blotting of cytosolic fractions for the cytosolic marker tubulin-a, but
not the nuclear marker lamin B. Data are representative of three replicate experiments. B) HeLa cells were transiently transfected with GFP-p65 in the
presence of mCherry alone, or mCherry AKIP 1A. After 30 hours, cells were serum starved overnight, fixed, and imaged as described in Methods and
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presence of AKIP 1A was linked to an increase in transcriptional
activity. HeLa cells were transfected with a luciferase gene reporter
downstream of a NF-kB response element (Fig. 6G) and stimulated
with TNFa for 1h. Enhanced luciferase activity was observed in all
cells expressing mCherry AKIP 1A compared to control cells,
whether serum starved or stimulated with TNFa.
A siRNA approach was employed to determine whether PKAc
could directly regulate the rate of p65 nuclear translocation in
response to TNFa (Fig. 7). PKAc (both a and b isoforms) was
knocked down in HeLa cells and the rate of p65 nuclear
translocation was measured as previously described. Cells with
reduced PKAc protein displayed a more robust translocation of
p65 to the nucleus in response to TNFa at 15 minutes compared
with cells transfected with a scrambled siRNA (lanes 2 and 5).
There was no difference in the amount of p65 in the nucleus in
unstimulated cells (lanes 1 and 4) or cells after 45 min of treatment
with TNFa (lanes 3 and 6).
Results from the siRNA experiments indicate that PKAc may
regulate the rate at which p65 enters the nucleus. Given that AKIP
1A is limiting in cells, we hypothesized that only a small
population of the PKAc and p65 exist in this complex. NF-kBi s
primarily retained in the cytosol by IkB isoforms that mask the
NLS on p65 [17]. Upstream activation by a number of stimuli,
including TNFa or PMA, results in phosphorylation of IkB and
subsequent targeting and degradation of IkB by the proteosome. It
is possible that the AKIP 1A, PKAc, p65 interaction we observe is
in a larger complex with other p65 binding proteins. This suggests
that AKIP 1A and PKAc may regulate something other than p65
directly. One logical thought was that AKIP 1A might influence
the rate of IkB degradation. To test this, HEK 293 cells mock
transfected or transfected with Myc-AKIP 1A were stimulated
with TNFa for up to 60 minutes then fractionated into cytosolic
and nuclear fractions. The Western blot in Fig. 8 (top panel) shows
the rate of IkBa degradation in the cytosol after TNFa stimulation
at 0, 20 and 60 minutes. Before addition of TNFa, cytosolic IkBa
levels of untransfected cells were identical with those transfected
with AKIP 1A and/or CAT 1-29 (lanes 1–4). After 20 min of
TNFa stimulation, there was a decrease in the amount of IkBa
protein in all samples with no concomitant increase in nuclear
IkBa detected (lanes 5–8). Consistent with other observations [22],
IkBa levels began to recover after 60 min (lanes 9–12). The
presence of AKIP 1A and/or CAT 1-29 did not significantly alter
the rate of IkBa degradation or synthesis, indicating that co-
localization of AKIP 1A and p65 does not interfere with canonical
NF-kB signal transduction.
Recently, Dong et al. found that mutation of the PKAc
phosphorylation site on p65 at position 276 to an alanine was
embryonic lethal [32]. Death in this system was attributed to
epigenetic repression through recruitment of histone deacetylases
to transcription hot-spots in the nucleus. Based on this
information, it was possible that AKIP1A was acting as an
adaptor protein that brings PKAc into the proximity of p65 and
facilitates phosphorylation. To test whether phosphorylation of
Ser 276 could be modulated by AKIP1A, we over-expressed
AKIP1A and/or CAT 1-29 in HeLa cells. After a 45 minute
incubation with TNFa/8CPT-cAMP (lanes 2, 4, 6, 8), phos-
phorylation at serine 276 in the cytosol was measured by Western
blotting and compared with serum starved cells (lanes 1, 3, 5, 7)
(Figure 9). In untransfected cells (lanes 3 and 4), phospho-276
levels were high in both starved and stimulated conditions.
Transfection with CAT 1-29 (lanes 1 and 2), AKIP 1A (lanes 7
and 8), and CAT 1-29/AKIP 1A (lanes 5 and 6) dramatically
lowered the amount of phosphor-276 observed in the cytosolic
fraction of cells.
Next, we wanted to determine whether mutation of serine 276
could mimic the nuclear translocation of p65 observed in the
presence of AKIP 1A and CAT 1-29. Serine 276 in p65 was
mutated to alanine (S276A) to mimic the dephosphorylated p65
and aspartic acid (S276D) to mimic the phosphorylated p65. HeLa
cells were transfected with each of the GFP-tagged constructs and
stimulated with TNFa for up to 45 minutes (Fig. 10A). Wild-type
p65 translocated to the nucleus with kinetics observed previously
(left panels). The S276A mutant rapidly accumulated in the
nucleus of cells in the absence of stimulus (middle panels).
Conversely, the S276D mutant displayed slightly delayed
translocation of p65 into the nucleus (right hand panels).
Biochemical fractionation of cytosolic and nuclear proteins from
HeLa cells transfected with Flag-tagged versions of the p65
constructs was performed to quantify translocation (Fig. 10 B and
C). More Flag-p65 WT was observed in the nuclear fractions at 0,
15, 30 minutes than with endogenous p65 (lanes 1, 2, and 3) which
may be an artifact of overexpression. However, under the same
conditions, there was substantially more p65 S276A observed in
the nucleus of unstimulated cells compared to wild-type p65 (lanes
5–8). Conversely, nuclear accumulation of p65 was slowed in the
S276D mutant (lanes 9–12).
Discussion
PKAc has been shown to trigger the activation and transloca-
tion of the p65 component of NF-kB. However, the mechanism of
translocation is unknown and was believed to be energy dependent
[33]. Furthermore, though the authors showed several years ago
that phosphorylation by PKAc was a key event in p65 activation
and translocation, the substrate for this reaction is still unknown
[33]. Our data shows that AKIP1 is the missing link regulating
both translocation and activation. We first demonstrate that AKIP
1A, the catalytic subunit of PKA, and the p65 subunit of NF-kB
can form a cytosolic complex. This complex could be modulated
through activators of PKA, overexpression of AKIP 1A, and over-
expression of a peptide (CAT 1-29) that blocks the interaction of
PKAc and AKIP 1A. Second, we show that both PKAc and
AKIP1 regulate the rate at which NF-kB translocates into the
nucleus in response to stimulus. TNFa mediated translocation of
p65 into the nucleus of HeLa cells was greatly enhanced either by
siRNA knock down of PKAc or over-expression of AKIP1. Third,
we provide further evidence showing that the phosphorylation of
p65 by PKAc is essential in its translocation. Expression of either
AKIP 1A or concomitantly with CAT 1-29 resulted in a
constitutive localization of p65 in the nucleus, indicating that
AKIP1 regulates the rate at which p65 enters the nucleus (Figs. 6D
and 6E). There was, however, no effect of AKIP 1A or CAT 1-29
on the rate of IkB degradation (Fig. 8), suggesting the canonical
NF-kB nuclear translocation pathway remained intact. IkBa was
demonstrated to be present in this complex (Fig. 3C), suggesting
that the pool of AKIP1 bound to PKAc and p65 overlaps with the
total population of cytosolic NF-kB.
Materials. C) Western blots of cytosolic fractions from immunoprecipitated Myc-AKIP 1A for PKAc, p65, and IkBa. Cytosol fractions were Western
blotted for soluble p65, PKAc, and IkBa as well as the tubulin (cytosolic marker) and lamin B (nuclear marker). Data shown is with Myc-AKIP 1A in the
absence (lanes 1 and 2) or presence of 8-CPT-cAMP (50 mM).
doi:10.1371/journal.pone.0018713.g003
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18713Figure 4. Defining sites of interaction on PKAc with AKIP 1A. A) Fifteen-residue peptides covering the catalytic domain (amino acids 1-38) of
PKAc were staggered by one amino acid, spotted onto a membrane, and probed with AKIP1 splice variants proteins. Binding was detected with anti-
AKIP1 antibody. The blot showed differential binding to the splice variants with the most intense binding to AKIP 1A, the full length protein. The
residues in orange are weak binding and in red the strongest binding peptides. B) The amino terminal helix of PKAc is highlighted with exposed
amino acids facing out towards the AKIP 1A binding surface: these amino acids may be important for the interaction with AKIP 1. C) HEK 293 cells
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endogenous AKIP 1A are significantly lower than p65 or PKAc.
The observation that AKIP1 isoforms are limiting in the complex
formation suggests that under normal cellular conditions, every
AKIP1 protein will be associated with both a PKAc and p65.
Therefore, when AKIP1 is no longer limiting, p65 nuclear
translocation is altered. Each one of these salient features is
addressed in detail below.
Isoform specificity dictates AKIP1 interactions
The two other groups that worked on AKIP1 showed either the
enhancement or abrogation of the transcriptional activity of p65
upon binding AKIP1. Though both groups have used similar
stimuli and cell lines, they obtained opposite results especially with
respect to the effects on the endogenous protein. Our studies found
that the cell lines used had very little AKIP1 (data not shown). In
human cell lines, the problem is further compounded by the
presence of splice variants and thus the results obtained could be
misleading. To clarify this problem, we systematically studied
isoform specificity of AKIP1 in multiple cell lines and found that
the predominant endogenous AKIP1 isoform present in the cells
was AKIP 1B (data not shown). Subsequently, we used
biochemical and peptide array technology to provide insight into
the function of the various AKIP1 isoforms and the interactions of
PKAc and p65. Biochemical data and peptide blot analysis
provide evidence that the 1A isoform of AKIP preferentially binds
PKAc (Fig. 1A and Fig. 4A). Binding to the N-terminus of PKAc
was similar to that of the full-length protein (compare Fig. 1A to
4A). One interacting region was detected in the array, amino acids
8-30 (KKGSEQESVKEFLAKAKEDFLKKW). This region of
PKAc is within the bait region originally used to identify AKIP1.
Peptide arrays further identified a major binding determinant for
PKAc was located in exons 5 and 6 of AKIP 1A (Fig. 5A). This
region has a putative PKAc phosphorylation site and thus provides
rationale for the increased binding observed between PKAc and
AKIP 1A. Though AKIP 1B also has these sites, the lack of exon 3
Figure 5. Identification of PKAc and p65 interaction sties on AKIP 1A by peptide array analysis. A peptide overlay of AKIP 1A with the
purified catalytic domain of PKAc and p65. Fifteen-residue peptides covering amino acids 1-210 of AKIP 1A staggered by five amino acids (A) or
eighteen-residue peptides covering amino acids 1-210 of AKIP 1A staggered by one amino acid (B) were spotted onto a membrane and overlaid with
recombinant PKAc (A) or in vitro translated p65 (B). Binding of PKAc and p65 binding were detected by Western blotting using antibodies to PKAc or
p65. The sequence, shown above or below the data, highlights the residues required for the interaction.
doi:10.1371/journal.pone.0018713.g005
were transfected with GST-AKIP 1A in the presence of the 1-29 PKAc disruptor peptide. Scrambled 1-29 peptide and a proline mutant at positions 20
and 22 to disrupt subsequent integrity of 1-29 helical structure served as controls. After 24 h, cells harvested and subjected to GST pull downs and
immunoblotting showed that AKIP1/PKAc interaction was disrupted by the 1-29 peptide but not the two controls. D) Quantification of the amount of
the relative amount of PKAc bound to GST-AKIP 1A. E) HeLa cells were transfected with Myc-AKIP 1A in the presence or absence of either CAT 1-29 or
scrambled CAT 1-29. Cells were stimulated with 8-CPT-cAMP (50 mM) or TNFa (1 ng/ml) for 1 hour, fractionated to obtain nuclear enriched fractions
and nuclear PKAc levels were measured by Western blot and quantified.
doi:10.1371/journal.pone.0018713.g004
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binding. Mapping studies of p65 binding sites on AKIP 1A point
to a conserved small region within exon 4 as the predominant
binding site (Fig. 5B). This region is common to all three AKIP1
isoforms, suggesting p65 might interact with all AKIP1 splice
variants. Evidence for p65 binding to multiple AKIP1 isoforms has
been demonstrated in two different studies [34,35]. These results
indicate that PKAc and p65 bind different regions of AKIP 1A
allowing them to form the complex. Furthermore, selective
disruption of the PKAc interaction through the CAT 1-29 peptide
does not affect the binding of p65 to AKIP 1A (data not shown).
These data have implications for the functions of the individual
isoforms of AKIP1. Recently, the role of AKIP1 in p65 mediated
gene expression has been studied. Subsequently, the AKIP 1A
isoform was identified as an enhancer of NF-kB dependent
transcription [34]. The difference between these effects was
postulated to be a result of agonist concentration, but may be
related to differential PKAc binding to the AKIP1 isoforms, rate of
p65 nuclear accumulation, or access of p65 to other binding
partners.
Stimulus and spatial localization regulate PKAc
interaction with AKIP1
Complicating the isoform-specific interactions of AKIP1 with
known binding partners is that elevation of cAMP accelerates
dissociation of PKAc from AKIP1. In whole cell lysate, stimulation
with 8-CPT cAMP results in a net dissociation of PKAc from
AKIP1 (Fig. 1A). This appears to be stimulus dependent because
no decrease in the interaction between PKAc and AKIP 1A was
observed in the presence of TNFa. Under all conditions such as
resting, serum starvation, or upon direct stimuli, the interaction
between AKIP1 and p65 remains constant. Given the interaction
of PKAc and AKIP1 in both the cytosolic and nuclear fractions of
cells, dissociation of PKAc from AKIP1 was further explored after
fractionation of cells. In the cytosol, 8-CPT cAMP there was no
change in the interaction (Fig. 3E). However, there was increase in
the nuclear accumalation of PKAc in the presence of AKIP1 and
increased transcription (Fig. 4E, 1B). However, we were unable to
establish either interaction or co-localization between PKAc and
AKIP1 in the nucleus either in the presence of 8-CPT cAMP or
TNFa (data not shown). We hypothesize that over-expression of
AKIP1 uncouples the PKAc and p65 interaction. This is based on
the change in relative nuclear accumulation of PKAc and p65 in
the presence of AKIP1. In Fig. 6E, both the rate and total p65
imported into the nucleus is increased in the presence of AKIP 1A
and CAT 1-29. Conversely, the amount of PKAc in the nucleus is
reduced under the same conditions though the amount of PKAc in
the nucleus remained unchanged in the presence of AKIP 1A
alone. Separately, we observe that AKIP1 dependent-PKAc
transcription is increased in the presence of stimulus where PKAc
is no longer associated with AKIP 1A (Fig. 1B). Taken together,
Figure 7. Knock down of endogenous PKAc accelerates nuclear
accumulation of endogenous p65. HeLa cells were transfected with
mock siRNA (lanes 1–3) or PKAc siRNA (lanes 4–6) for 36 hours, serum
starved for 12 hours, and then stimulated with TNFa for 0, 15, or
45 min. Samples were analyzed on 10% SDS-polyacrylamide gels and
Western blotted with antibodies to p65, PKAc, and lamin B.
doi:10.1371/journal.pone.0018713.g007
Figure 8. AKIP 1A and CAT 1-29 do not alter IkBa degradation
rates after TNFa stimulation. HeLa cells were transfected with Myc-
AKIP 1A in the presence or absence of HA-CAT 1-29 and stimulated with
TNFa for 0, 20, or 60 min with TNFa. Representative Western are shown
of samples analyzed on 10% SDS-polyacrylamide gels and Western
blotted with antibodies to p65, PKAc, and lamin B.
doi:10.1371/journal.pone.0018713.g008
Figure 6. Blocking access of PKAc to p65 accelerates the kinetics of nuclear translocation of p65 in the presence of TNFa and
augments p65 transcriptional activity. HeLa cells transfected with A) GFP-p65 WT alone, or with B) CAT 1-29 peptide, C) mCherry AKIP 1A, or D)
both CAT 1-29 peptide andmCherry AKIP 1A. Cellswere stimulated with TNFa (1 ng/ml) for 0,15, 30 or 45 min, then fixed andpermeabilized. Data were
collected as described in Methods and Materials. DAPI staining of the nucleus and merged images are shown for each of the conditions in lower panels.
E)HEK293cellstransfectedwitheithermCherryAKIP 1A,scrambledCAT1-29 peptide,CAT1-29peptide,ormCherryAKIP 1AandCAT1-29peptidewere
stimulatedwith TNFa for 0, 15, 30, or 45 min.Representative Western blots demonstrate the accumulation of endogenous p65 in the nucleus compared
to total p65 levels. F) Quantification of nuclear p65 levels. The amount of nuclear p65 was calculated based on normalized values of total p65 protein. G)
HeLa cells were transfected with a NF-kB luciferase reporter in the presence of either mCherry alone or mCherry AKIP 1A and stimulated for up to 1 h
with TNFa (1 ng/ml). Increased basal and TNFa stimulated p65 transcriptional activity was observed in the presence of AKIP 1A.
doi:10.1371/journal.pone.0018713.g006
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the nucleus, but that PKAc is rapidly dissociated from the complex
once inside.
Regulation of the rate of NF-kB translocation upon
phosphorylation
Though NF-kB has been shown to be a substrate of PKA, the
downstream effects of it on translocation and transcription are still
largely an enigma. One paper suggested that the level of AKIP1
plays a determining role in either the activation or inhibition of
p65 resulting in cell proliferation or cell death in cancer cell lines
[36]. We show that AKIP1 is important also in regulating the rate
of p65 into the nucleus. We next investigated whether this is a
consequence of serine 276 phosphorylation or through some other
mechanism. Phosphorylation of serine 276 on p65, a well
described PKAc site, in cytosolic fractions was dramatically
reduced in TNFa stimulated cells expressing AKIP 1A and/or
CAT 1-29, suggesting that phosphorylation of p65 by PKAc
regulated nuclear import. Mutation of serine 276 to alanine
resulted in strong, constitutive nuclear localization of p65, while
mutation to the phosphomimetic aspartic acid displayed reduced
nuclear translocation kinetics (Fig. 10A and B). Thus, AKIP 1A
serves as a scaffold that allows PKAc proximal contact with p65 in
the cytosol and protects the serine 276 site from being
phosphorylated. Work from Dong, et al. described the results
from a knock-in mouse expressing NF-kB S276A mutant that were
embryonic lethal [32]. In the wild-type animals, p65 phosphor-
ylated at serine 276 could recruit CBP/p300 to specific
transcription sites, however, when serine 276 was mutated to
alanine, HDAC3 replaced CBP/p300 binding on p65. The lack of
recruitment alone was insufficient to explain the lethality. The
presence of HDAC3 acts by epigenetic repression of genes
proximal to NF-kB sites. Thus, given the importance of serine
276 phosphorylation in the nucleus, we identified AKIP1 as not
only an important regulator of nuclear translocation of p65 by
positioning PKAc in proximity of serine 276 but also important in
retaining both p65 and PKAc and enhancing their transcription.
We postulate that this could be through AKIP1 shielding the
phosphorylation site of p65 in the cytosol from PKAc, enhancing
the translocation to the nucleus, wherein we believe PKAc
phosphorylates p65 and is released from the complex allowing for
the recruitment of CBP/p300 (Fig. 11). One aspect that has to be
delved into is the mechanism of action of the various isoforms of
AKIP1 in recruiting CBP/p300 or HDACs. These studies would
lay a foundation for determining the role of AKIP1 in PKA
mediated NF-kB transcription and in turn lead to a better
understanding of cell proliferation and differentiation.
Materials and Methods
Reagents
The monoclonal antibody to PKAc was purchased from BD
Biosciences (San Jose, CA, USA). An antibody to the Flag epitope
was purchased from Sigma (St Louis, MO, USA). Antibodies to
p65, phospho-NF-kB p65 (Ser 276), IkBa, and GST were
purchased from Cell Signaling (Danvers, MA, USA). Antibodies
to actin, tubulin, and lamin B were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). GFP- NF-kB p65 was a
generous gift from Dr. Mel Simon (UCSD). Control siRNA and
siRNA to PKAc was purchased from Santa Cruz Biotechnology.
TNFa was purchased from Roche (San Francisco, CA, USA) and
8CPT-cAMP was purchased from Sigma Aldrich (St. Louis, MO).
All other materials were reagent grade.
cDNA constructs and Plasmids
Human AKIP 1A, AKIP 1B, and AKIP 1C were cloned into
the pEBG vector containing an amino-terminal GST epitope tag.
Myc AKIP 1A was generated by cloning into the pCMV Myc
vector using Nco1 and Kpn1 restriction endonuclease sites.
mCherry AKIP 1A was generated by cloning into the pCDNA3
mCherry vector using HindIII and Xho1 restriction endonuclease
sites. HA-CAT 1-29 was generated by PCR amplification using
the following primers: 59 TAACAATGTACCCATACGATGT-
TCCGGATTACGCTatgggcaacgccgccgcc and 39 ggagagcgtgaaa-
gagttcctagccaaagccaaggaagatttcctgaaaaaatgaGCGGCCGCgat cc-
tctcgcactttctcaaggatcggtttcggttccttctaaaggacttttttactcgccggcgctag
CCCGGGCCCGCGGTACCGTCGACTGCAGAATTAtcatt-
ttttcaggaaatc. HA-CAT Scrambled was generated by PCR am-
plification using the following primers: 59 TAACAATGTACC-
CATACGATGTTCCGGATTACGCTatggccagcgagaaagag and
39 ccctaaaaaaccaggccaagggcagcaagaaattcgaactggaggtgttcggcgcctg-
a gggattttttggtccggttcccgtcgttctttaagcttgacctccacaagccgcggact CC-
CGGGCCCGCGGTACCGTCGACTGCAGAATTAtcaggcgcc-
gaacacctc. Both products were cloned into the phCMV-Xi clone
vector using homologous recombination.
Cell Culture and Transfection
All cell lines used in these studies (HEK 293 and HeLa; ATCC
CRL-1573 and CCL-2, respectively) were maintained in
Dulbecco’s modified Eagle’s medium (DMEM, BioWhittiker,
Basel, Switzerland) containing 10% heat-inactivated fetal bovine
serum (Omega Scientific Inc., San Diego, CA, USA). For
transfections, cells (seeded at 1.2610
6 cells/10-cm dish) were
grown to 70% confluence and transfected (2 mg total plasmid
DNA and 60 ml Effectene per 10 cm dish) according to the
manufacturer’s protocol (Qiagen, Valencia, CA, USA). Thirty
hours post transfection, cells were transferred to serum-free media
for 18 h, and stimulated with 50 mM 8CPT-cAMP and/or 1 ng/
ml TNFa.
Cell Fractionation
Cells were fractionated using the Qproteome cell compartment
kit to generate cytosolic and nuclear pools as described by the
manufacturer (Qiagen).
Figure 9. Disruption of the interaction between AKIP 1A and
PKAc decreases phosphorylation of p65 at serine 276 in the
cytosol. HeLa cells were transfected with CAT 1-29 (lanes 1 and 2), AKIP
1A (lanes 7 and 8), or CAT 1-29 and AKIP 1A (lanes 5 and 6) in the
absence (lanes 1, 3, 5, 7) or presence (lanes 2, 4, 6, 8) of TNFa/8-CPT-
cAMP. Samples were fractionated and the cytosolic fraction analyzed on
10% SDS-polyacrylamide gels and Western blotted with antibodies to
phospho-Ser 276 p65 and p65. Lines indicate duplicate samples.
doi:10.1371/journal.pone.0018713.g009
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acid slows nuclear translocation. A) HeLa cells transfected with GFP-p65 WT, GFP-p65 S276A, or GFP-p65 S276D were stimulated with TNFa
(1 ng/ml) for 0, 15, or 45 min. Cells were fixed and data were collected as described in the Methods section. B) HEK 293 cells were transfected with
Flag-p65 WT (lanes 1–4), Flag-p65 S276A (lanes 5–8), or Flag-p65 S276D (lanes 9–12) and stimulated with TNFa (1 ng/ml) for 0, 15, 30, or 45 min.
Representative Western blots demonstrate the accumulation of the different p65 constructs in the nucleus compared to total p65 levels.
C) Quantification of nuclear p65 levels calculated based on normalized values of total p65 protein. Legend: p65 alone (%), p65 S276A (&), p65
S276D (D).
doi:10.1371/journal.pone.0018713.g010
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The PKA and NF-kB activity was determined using the Dual-
LuciferaseH Reporter (DLR
TM) Assay System (Promega) accord-
ing to the manufacture’s instructions. Briefly, HeLa cells were
cultured in 24 well plates and the cells were transfected with
FuGENE 6 transfection reagent (Roche). To determine PKA
activity, cells were co-transfected with 125ng of pGL4 CRE
(cAMP response element) Luc2, 25 ng of pRL (hRluc gene that
expresses the Renilla luciferase as a internal control) together with
125 ng of mCherry AKIP1A or mCherry for 18 hours and then
the cells were stimulated with 100 mM forsokolin/IBMX for 0,
30, 60 and 120 mins. Similarly, to monitor NF-kB activity, cells
were co-transfected with 125 ng of pGL-3kB HIV-Luc, 25 ng of
pRL along with 125 ng of mCherry AKIP1A or mCherry. The
cells were stimulated with 10ng/ml of TNFa for 0, 15, 30 and 60
minutes. The cells were then harvested in 100 ml of passive lysis
buffer and subjected to the DLR activity assay. The output of the
luciferase assays was in relative light units (RLU). Promoter
activity bar graphs were generated and statistical analysis of the
data performed using MS Office Excel and the GraphPad Prism
software (GraphPad Prism software Inc., US).
GST Fusion Protein Pull-down Assay
HeLa cells were transiently transfected with GST-tagged AKIP
1A, AKIP 1B, or AKIP 1C. Transfected cells were lysed in buffer
A (50 mm Na2HPO4, 1 mm sodium pyrophosphate, 20 mm NaF,
2 mm EDTA, 2 mm EGTA, 1% Triton X-100, 1 mm dithio-
threitol, 200 mm benzamidine, 40 mgm l
21 leupeptin, 300 mmphe-
nylmethylsulfonyl fluoride). The detergent-solublized cell lysates
were incubated with glutathione-Sepharose overnight at 4uC.
Beads were washed twice in buffer A and twice in buffer B
(300 mm NaCl, 50 mm Na2HPO4, 1 mm sodium pyrophosphate,
20 mm NaF, 2 mm EDTA, 2 mm EGTA, 1% Triton X-100,
1 mm dithiothreitol, 200 mm benzamidine, 40 mgm l
21 leupeptin,
300 mmphenylmethylsulfonyl fluoride), and proteins bound to the
glutathione-Sepharose beads were analyzed by SDS-PAGE and
Western blot analysis using chemiluminescence and quantified
with a CCD camera using a Fluoro-Chem Q bio-imaging system
(Alpha Innotech, Santa Clara, CA, USA).
AKIP1 Overlay of the Catalytic Domain of PKA
The catalytic domain of PKA was divided into 18-amino-acid
peptides, with a single amino-acid shift, and synthesized using the
INTAVIS MultiPep peptide synthesizer (INTAVIS Bioanalytical
Instruments AG, Koeln, Germany), which spotted the peptides
onto an AC-S01 type amino-PEGylated membrane (INTAVIS
AG). Following activation with ethanol, the membrane was
blocked, washed with PBS-T, and incubated overnight with
100 nM human AKIP1 protein. This protein was generated by
using untagged pRSET construct of AKIP 1A that was in vitro
translated using rabbit reticlulate lysate. After incubation with the
AKIP 1A, the peptide array was analyzed by Western blot analysis
with polyclonal rabbit AKIP1 antibody generated previously (11).
Immunoprecipitation
Antibodies to transfected Myc and Flag tagged constructs were
used to immunoprecipitate proteins from cell lysates. Detergent
soluble cell lysates and the indicated specific antibodies were
incubated in binding buffer (100 mM KCl, 150 mM NaCl,
3.5 mM MgCl2, 10 mM Pipes, pH 7.3, 1 mM DTT, and 1 mM
PMSF) overnight at 4uC, followed by a 1 h incubation with bovine
serum albumin (Sigma)-coated protein A/G-Sepharose beads (GE
Healthcare, Piscataway, NJ, USA). Beads were pelleted by
centrifugation, and the pellet was washed three times in binding
buffer containing 1% Nonidet-40 and three times in binding buffer
alone. Immunoprecipitated proteins were separated by SDS-
PAGE, transferred to nitrocellulose, and detected by Western Blot
analysis.
Immunofluorescence
HeLa cells grown on sterile coverslips were transfected with
various GFP-p65 constructs in the absence or presence of
mCherry AKIP 1A and/or HA-CAT 1-39 at 40% confluency.
After 24 hours, cells were fixed with 4% paraformaldehyde for
Figure 11. Model for PKAc-mediated enhanced p65 nuclear translocation. Translocation of p65 to the nucleus is regulated by external
stimuli and canonical TNFa stimulation. Accelerated nuclear accumulation p65 is observed by disrupting the interaction between PKAc and AKIP,
overexpressing the limiting AKIP, or by mutation of the PKAc phosphorylation site at serine 276 to alanine. Nuclear accumulation of p65 can be
delayed by replacing serine 276 with a phosphomimetic.
doi:10.1371/journal.pone.0018713.g011
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for 5 min and washed three times with PBS. After several washes
with PBS containing 0.1% Triton X-100, the samples were
mounted with Vectashield Hardset media containing DAPI
(Vector Laboratories, Burlingame, CA, USA) and images were
acquired on a Zeiss Axiovert microscope (Carl Zeiss Microima-
ging, Inc., Thornwood, NY, USA) using a MicroMax digital
camera (Roper-Princeton Instruments, Acton, MA, USA) con-
trolled by MetaFluor software (Universal Imaging, Corp.,
Sunnyvale, CA, USA).
Supporting Information
Figure S1 A peptide overlay of the catalytic domain of PKAc
with purified AKIP 1A. Fifteen-residue peptides covering the
catalytic domain (amino acids 1-38) of PKAc staggered by one
amino acid were spotted onto a membrane and overlaid with in
vitro translated AKIP 1A (Pierce, TNT kit), and AKIP 1A binding
was detected with a polyclonal anti-AKIP antibody. The residues
highlighted in orange are weak binding peptides, and the residues
highlighted in red are the residues delineating the stronger binding
peptides. The boxed peptides were the strongest binders.
(TIF)
Figure S2 A peptide overlay of AKIP 1A with the purified
catalytic domain of PKAc. The strongest AKIP1 binding peptide
on PKAc, identified in Figure 2A, was sequentially truncated from
the amino and carboxy terminal ends, as well as from both ends
simultaneously to define the minimal PKAc binding peptide
region. Peptides were spotted onto a membrane and overlaid with
purified PKAc and p65 and detected by Western blotting using
anti-PKAc or p65 antibodies.
(TIF)
Figure S3 Graph of p65 nuclear translocation of p65 in the
presence of TNF/8CPT. HeLa cells transfected with Cells were
stimulated with TNFa (1 ng/ml) for 0, 15, 30 or 45 min, then fixed
and imaged. Data shown is quantification of nuclear p65 levels
based on normalized values of total p65 protein (n=3). Legend:
p65 alone (&), p65 + AKIP 1A (m), p65 + AKIP 1A + CAT 1-29
(#), and p65 + CAT 1-29 (%).
(TIF)
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